Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment.

about

Saccharomyces cerevisiae Laryngitis and Oral Lesions in a Patient with Laryngeal Carcinoma.

P2860

Q48275354-705BEF89-E7C2-4103-981F-1343EA88158F

P2860

Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment.

Item

http://www.wikidata.org/entity/Q40099400

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment.

@en

type

Item

label

Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment.

@en

prefLabel

Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment.

@en

P1476

Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment

@en

P2093

Gabriel A Narvaez

http://www.w3.org/2001/XMLSchema#string

Jairo Lewgoy

http://www.w3.org/2001/XMLSchema#string

Laura Drehmer

http://www.w3.org/2001/XMLSchema#string

Leandro R R Perez

http://www.w3.org/2001/XMLSchema#string

P2860

Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa

Saccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticum

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea.

The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene.

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.

Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: A Randomized, Double-Masked, Placebo-Controlled Trial

Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis.

Extreme Dysbiosis of the Microbiome in Critical Illness.

Probiotics for the prevention of antibiotic-associated diarrhoea in older patients: a systematic review.

P304

15-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MMCR.2017.07.007

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marcelo C Appel-da-Silva

P577

2017-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28794958

http://www.w3.org/2001/XMLSchema#string

P921

probiotics

P932

5537395

http://www.w3.org/2001/XMLSchema#string

Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment.

about

P2860

P2860

Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932